Literature DB >> 2073119

In vitro activities of new antimicrobial agents against multiresistant Staphylococcus aureus isolated from septicemic patients during a Belgian national survey from 1983 to 1985.

P Van der Auwera1, C Godard, C Denis, S De Maeyer, R Vanhoof.   

Abstract

The antimicrobial agents most active against bacteremic isolates of oxacillin-resistant Staphylococcus aureus isolated from 1983 to 1985 were new fluoroquinolones, including PD 117,596 and PD 127,391 (MIC for 90% of isolates [MIC90] in agar, in micrograms per milliliter, 0.1) and temafloxacin, pefloxacin, and ofloxacin (MIC90, 0.4). Other active antimicrobial agents included fusidic acid (MIC90, 0.2) and fosfomycin (MIC90, 12.5). Vancomycin was active against all isolates. Mupirocin was very active (MIC90, 0.4).

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2073119      PMCID： PMC172034          DOI： 10.1128/AAC.34.11.2260

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  8 in total

Review 1.  Mupirocin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  A Ward; D M Campoli-Richards
Journal:  Drugs       Date:  1986-11       Impact factor: 9.546

2.  In-vitro activity of two new carbapenems FCE 22101 and CGP 31608 in comparison with imipenem.

Authors:  P Van der Auwera; F Ernst; P Grenier; Y Glupczynski; M Husson; J Klastersky
Journal:  J Antimicrob Chemother       Date:  1987-08       Impact factor: 5.790

3.  In vitro activities of PD 117,596 and reference antibiotics against 448 clinical bacterial strains.

Authors:  R P Smith; A L Baltch; M C Hammer; J V Conroy
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

4.  Widespread quinolone resistance among methicillin-resistant Staphylococcus aureus isolates in a general hospital.

Authors:  I Shalit; S A Berger; A Gorea; H Frimerman
Journal:  Antimicrob Agents Chemother       Date:  1989-04       Impact factor: 5.191

5.  A general survey of antibiotic treatment of staphylococcal septicaemia and endocarditis.

Authors:  C Watanakunakorn
Journal:  Scand J Infect Dis Suppl       Date:  1983

6.  In vitro activity of PD 127,391, an enhanced-spectrum quinolone.

Authors:  R Wise; J P Ashby; J M Andrews
Journal:  Antimicrob Agents Chemother       Date:  1988-08       Impact factor: 5.191

7.  Comparative in vitro activity of PD 127,391, a new fluorinated 4-quinolone derivative.

Authors:  S R Norrby; M Jonsson
Journal:  Antimicrob Agents Chemother       Date:  1988-08       Impact factor: 5.191

8.  Mechanism of mupirocin transport into sensitive and resistant bacteria.

Authors:  J O Capobianco; C C Doran; R C Goldman
Journal:  Antimicrob Agents Chemother       Date:  1989-02       Impact factor: 5.191
  8 in total
  8 in total

Review 1.  Fosfomycin: an old, new friend?

Authors:  M Popovic; D Steinort; S Pillai; C Joukhadar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-11-14       Impact factor: 3.267

2.  Association of mutations in grlA and gyrA topoisomerase genes with resistance to ciprofloxacin in epidemic and sporadic isolates of methicillin-resistant Staphylococcus aureus.

Authors:  A Deplano; A Zekhnini; N Allali; M Couturier; M J Struelens
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

3.  Antistaphylococcal activity of ceftobiprole, a new broad-spectrum cephalosporin.

Authors:  Tatiana Bogdanovich; Lois M Ednie; Stuart Shapiro; Peter C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

4.  National survey of methicillin-resistant Staphylococcus aureus in Belgian hospitals: detection methods, prevalence trends and infection control measures. The Groupement pour le Dépistage, l'Etude et la Prévention des Infections Hospitalières.

Authors:  M J Struelens; R Mertens
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-01       Impact factor: 3.267

5.  A prospective, randomized study of pefloxacin versus teicoplanin in the treatment of gram-positive coccal infections in cancer patients: early termination due to emergence of resistance to fluoroquinolones.

Authors:  M Aoun; P Van der Auwera; I Varthalitis; A M Bourguignon; M Janssen; D Daneau; F Meunier
Journal:  Support Care Cancer       Date:  1994-05       Impact factor: 3.603

6.  Pharmacokinetics of intravenous fusidic acid in patients with cholestasis.

Authors:  J D Peter; F Jehl; T Pottecher; J P Dupeyron; H Monteil
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

7.  Comparative in vitro activity of PD 127391, a new fluoroquinolone agent, against susceptible and resistant clinical isolates of gram-positive cocci.

Authors:  A G Miranda; A R Wanger; K V Singh; B E Murray
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

8.  Epidemiologic typing and delineation of genetic relatedness of methicillin-resistant Staphylococcus aureus by macrorestriction analysis of genomic DNA by using pulsed-field gel electrophoresis.

Authors:  M J Struelens; A Deplano; C Godard; N Maes; E Serruys
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.